Articles written by Lisa Phillips:

Aveanna Healthcare Calls Off Maxim Home Health Merger

The Federal Trade Commission has done it again. The agency closed its investigation into the merger of Aveanna Healthcare with Maxim Healthcare‘s home health division, announced in February 2019. We’re accustomed to seeing headlines every few months saying the FTC plans to tighten scrutiny of hospital mergers and acquisitions. The anti-trust division has been active […]

gene-editing
gene-editing

Belgian CDMO Acquired by Catalent

Catalent, Inc. (NYSE: CTLT) announced a $315 million deal for MaSTherCell Global, a technology-focused cell and gene therapy contract development and manufacturing organization based in Gosselies, Belgium. It is backed by Great Point Partners, SFPI-FPIM (the Belgian Federal Holdings and Investment Company) and Orgenesis Inc. (NASDAQ: ORGS). This is the Somerset, New Jersey-based CRO’s fifth […]

Saga Continues for St. Christopher’s Hospital for Children

Where there’s a hospital or health system filing for bankruptcy protection, there’s usually a sale in the offing that involves a real estate investment trust. That’s the most recent twist in the story of St. Christopher’s Hospital for Children, which we first reported in September 2019. The 188-bed hospital, a critical safety-net hospital for children […]

Laboratories
Laboratories

Quest Acquires Memorial Hermann Outreach Labs

Quest Diagnostics (NYSE: DGX) has had a busy month. On January 22, it acquired Blueprint Genetics, a leading genetic testing company based in Helsinki, Finland, for an undisclosed amount. Now, it’s turned its sites back home. On January 27, it announced a deal for substantially all of the Memorial Hermann Diagnostic Laboratories (MDHL), the outreach […]

Chromosomes
Chromosomes

Quest Diagnostics Buys Genetic Testing Company

Quest Diagnostics (NYSE: DGX) broadened its scope in genetics and rare diseases with the January 22 acquisition of Blueprint Genetics, based in Helsinki, Finland. Founded in 2012, the target now serves customers in more than 70 countries. Financial terms of the all-cash equity transaction were not disclosed. Blueprint is a leading specialty genetic testing company […]

Summit BHC Moves into Colorado

It’s been some time since we heard about Summit BHC. There’s a good reason, too. It hasn’t announced an acquisition since October 2018. Now comes news the firm has moved into Colorado, making its first acquisition in the state. On January 22, the company added Peak View Behavioral Health, a 112-bed acute psychiatric and behavioral […]

eHealth
eHealth

Hospital M&A Outlook

The Hospital sector ended 2019 with 80 transactions in the United States reaching the definitive agreement stage or closing. All told, 99 hospital deals are on the books for the year, which is a 25% increase over 2018’s 79 hospital deals. For the fourth quarter of 2019, 23 transactions reached the definitive agreement stage or […]

Seroquel
Seroquel

Eli Lilly Comes Out Swinging

The annual J.P. Morgan Healthcare conference in San Francisco concluded last week with very few big deal announcements. In January 2019, Bristol-Myers Squibb (NYSE: BMY) made its $74 billion takeover of Celgene Corporation (NASDAQ: CELG) public just before the conference started. That was quickly followed by Eli Lilly and Company‘s (NYSE: LLY) $8 billion deal […]